MedTrace Logo

A Mobile Intervention to Improve Uptake of PrEP for Southern Black MSM

NCT03308097 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2021-02-21

Study results available
· View outcomes & findings →

Summary

This study will develop and test an interactive mobile messaging intervention to improve engagement in care related to Pre-exposure Prophylaxis (PrEP) and decrease HIV risk behaviors for Black men who have sex with men living in the Southern U.S. The mobile messaging intervention will include interactive text messaging and free, publicly available links to websites and YouTube videos. During the intervention participants will gain information about their health, improve motivation for engagement in PrEP related care, and build skills for healthy behaviors. Participants will also receive intervention materials to help decrease frequent barriers to care. If the intervention is found to be effective, it can be tested in a larger study and then disseminated.

Conditions

Interventions

BEHAVIORAL

PrEP Mobile Messaging Intervention

See group description

BEHAVIORAL

Enhanced Standard of Care

See group description

Sponsors & Collaborators

  • University of Mississippi Medical Center

    collaborator OTHER

  • Rhode Island Hospital

    lead OTHER

Principal Investigators

  • Larry K. Brown, M.D. · Rhode Island Hospital

  • Laura Whiteley, M.D. · Rhode Island Hospital

  • Leandro Mena, M.D. · University of Mississippi Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-20
Primary Completion
2020-08-12
Completion
2020-08-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03308097 on ClinicalTrials.gov